Statistics for Lexicon Pharmaceuticals (id:8009 LXRX)

Valuation metrics

Market cap

327.15M

Enterprise value

194.05M

Trailing P/E (ttm)

-1.09

Forward P/E

-1.51

PEG ratio

-1.51

Price/Sales (ttm)

62.56

Price/Book (mrq)

1.83

Enterprise Value/Revenue

37.11

Enterprise Value/EBITDA

-0.92

Overview

Shares outstanding

361.49M

Float

182.14M

Shares short

28.65M

% Held by insiders

0.01%

% Held by institutions

0.82%

Average volume (10 days)

3.64M

Average volume (90 days)

Price summary

52-Week low

0.73

52-Week high

3.73

52-Week change

-29.07%

Beta

1.24

50-Day moving average

1.61

200-Day moving average

1.89

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

May 21th, 2015

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

92.94%

Operating margin

-3,639.60%

Operational effectiveness

Return on assets

-44.16%

Return on equity

-136.09%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

1.12M

EBITDA

-210,552,992.00

Net income to common (ttm)

-216,392,992.00

Diluted EPS (ttm)

-0.74

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

258.37M

Total cash per share (mrq)

0.72

Total debt (mrq)

99.90M

Total Debt/Equity (mrq)

55.96

Current ratio (mrq)

745.18%

Book value per share (mrq)

0.49

Cash flow

Cash flow statement

-158,998,000.00

Levered free cash flow (LFCF)

-177,119,000.00